SCHEMBL7814229

SCHEMBL7814229

CC(C)(Oc1cccc(C2=CCN(C(=O)c3ccc4ccccc4n3)CC2)c1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
PPARG P37231 6/20 0.45
PPARA Q07869 4/20 0.45
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.42
GAA P10253 2/20 0.42
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 1/20 0.39
SHMT2 P34897 1/20 0.39
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
PDE10A Q9Y233 1/20 0.38
GRIN2B Q13224 1/20 0.38
CCKAR P32238 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811458 0.91 GAA (0.47) ALDH1A1SMN1; SMN2PPARGPPARAMAPT
SCHEMBL7817532 0.89 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2PPARGPPARAMAPT
SCHEMBL7813666 0.84 PPARG (0.52) ALDH1A1SMN1; SMN2PPARGPPARAMAPT
SCHEMBL7814214 0.83 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2PPARGPPARAMAPT
SCHEMBL7804398 0.81 PPARG (0.49) ALDH1A1SMN1; SMN2PPARGPPARAMAPT
SCHEMBL7810037 0.80 PPARG (0.50) ALDH1A1SMN1; SMN2PPARGPPARAMAPT
SCHEMBL7804335 0.79 TSHR (0.67) ALDH1A1SMN1; SMN2PPARGMAPTTSHR
SCHEMBL7811577 0.79 PPARG (0.49) ALDH1A1SMN1; SMN2PPARGPPARAMAPT
SCHEMBL7811630 0.79 PPARA (0.60) ALDH1A1SMN1; SMN2PPARGPPARAMAPT
SCHEMBL7811760 0.79 PPARG (0.49) ALDH1A1SMN1; SMN2PPARGPPARAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed